An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

A recent study conducted by the Chinese Academy of Sciences has brought attention to a potential link between frequent ...

"For the first time, we have a drug which is effective in inhibiting both these regions. "This dual-targeting mechanism is significant ... test that could predict dementia up to nine years ...

The research, published in Alzheimer's & Dementia ... we have a drug which is effective in inhibiting both these regions. This dual-targeting mechanism is significant because it addresses both ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

He said the “devastating progressive” disease was responsible for 10 to 20 per cent of all dementia cases but hoped their drug – based on a non-toxic, naturally occurring compound called ...